FDA Unveils Rx Safety Board, Website; Postmarket Surveillance Overhaul Next
Executive Summary
HHS is planning a major overhaul of FDA's postmarketing surveillance system as the centerpiece of its next announcement about upgrades to the drug safety regulatory system